Samuel A. Hamood - 01 Oct 2021 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Director
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol
FNCH
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
05 Oct 2021, 19:53:17 UTC
Previous filing
15 Sep 2021
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FNCH Stock Option (right to buy) Award $0 +25,543 $0.000000 25,543 01 Oct 2021 Common Stock 25,543 $12.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3rd) of the shares subject to the option vest on October 1, 2022, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.